H8Y.F Exosens
- Market cap
- EUR 2.67B
- P/E
- 125.2x
- P/B
- 6.03x
- ROE
- 6.9%
- Dividend yield
- 0.19%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is H8Y.F undervalued?
Graham numberThe Graham number of Exosens cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Exosens fundamental analysis
No fundamental analysis for Exosens yet.
Exosens stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Exosens
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions a…
Full company profileExosens financial statements
Exosens annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 166M | 201M | 292M | 468M | 383M |
| Gross Profit | 100M | 114M | 212M | 278M | 222M |
| Operating Income | 32.4M | 33.0M | 54.6M | 102M | 80.6M |
| EBITDA | - | 51.2M | 75.3M | 142M | 120M |
| Net Income | -149M | 11.2M | 18.4M | 42.7M | 30.7M |
| EPS | -2.93 | 0.22 | 0.36 | 0.84 | 0.60 |
| Balance Sheet | |||||
| Total Assets | 461M | 529M | 656M | 817M | 879M |
| Total Liabilities | 288M | 346M | 452M | 404M | 433M |
| Shareholders' Equity | 172M | 183M | 204M | 413M | 446M |
| Cash & Short-term Investments | 15.9M | 29.0M | 15.5M | 117M | 68.6M |
| Cash Flow | |||||
| Operating Cash Flow | 42.7M | 47.5M | 50.5M | 98.8M | 107M |
| Capital Expenditure | 0.00 | 21.8M | 30.9M | 0.00 | 0.00 |
| Free Cash Flow | 42.7M | 25.7M | 50.5M | 98.8M | 107M |
| Ratios | |||||
| ROE | -86.6% | 6.1% | 9.0% | 10.3% | 6.9% |
| ROA | -32.3% | 2.1% | 2.8% | 5.2% | 3.5% |
| Net Profit Margin | -89.6% | 5.6% | 6.3% | 9.1% | 8.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Exosens dividends
- Dividend yield
- 0.19%
- Forward dividend
- 0.30 EUR
- Payout ratio
- 16.6%
- Ex-dividend date
- May 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 5.10M | 0.10 | 16.6% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Exosens
- Insiders 31.25%
- Institutions 47.70%
- Public & others 21.05%
- Shares outstanding 50.7M
- Free float 32.8M
Exosens company profile
- Company name
- Exosens
- Ticker
- H8Y.F
- ISIN
- FR001400Q9V2
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Employees
- 2,000
- Fiscal year end
- December
- Address
- Building 5, Mérignac, France, 33700
- Phone
- 33 5 56 16 40 50
- Website
- exosens.com
About Exosens
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.
Exosens management
10- Mr. Jerome CerisierCEO & Director · born 1973
- Ms. Quynh-Boi DemeyChief Financial Officer
- Mr. Pascal JosephChief Operating Officer
- Dr. Christel-Loic TisseChief Technology Officer · born 1976
- Ms. Bella ZisereChief People & Culture officer
- Ms. Claire ValentinHead of the Instruments Division
- Mr. Fred LalkensChief Program Officer
- Mr. Frederic GuilhemChief Commercial Officer - Night Vision
- Mr. Paul RyckaertChief Strategy Officer
- Guillaume BunozHead of Imaging Division